Product Information
LIPITOR 40 MG TABLET is a brand product labeled by Pfizer Inc., priced at $19.1970 per EA under NDC 00071015723. Its NADAC has been published 636 times since Nov 28, 2013.
FDA first approved this application on Dec 17, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the atorvastatin calcium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Pfizer Inc.NDC
00071015723
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA020702FDA Approved
12/17/1996
TE Code
AB
On Market Since
12/17/1996
Pharmacological Classes
Price Statistics
The NADAC for LIPITOR 40 MG TABLET has been published 636 times since Nov 28, 2013, and over the history we have for it it has risen 195.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1970 per EA |
|---|---|
| All-time high | $19.1970 (Apr 1, 2026) |
| All-time low | $6.4867 (Nov 28, 2013) |
| 52-week high | $19.1970 |
| 52-week low | $18.2095 |
| Median price | $14.8346 |
| Average price | $13.8476 |
| Largest weekly change | +9.4% (Jun 7, 2017) |
| Weeks tracked | 636 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
+5.4%
3Y
+13.5%
5Y
+21.3%
All
+195.9%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LIPITOR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LIPITOR 40 MG TABLET, manufactured by Pfizer Inc., is $19.1970 per EA (NDC 00071015723), effective Apr 1, 2026.
How has the price of LIPITOR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for LIPITOR 40 MG TABLET has risen 195.9%. It has been tracked across 636 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LIPITOR 40 MG TABLET?
Since Nov 28, 2013, the NADAC for LIPITOR 40 MG TABLET has ranged from a low of $6.4867 (Nov 28, 2013) to a high of $19.1970 (Apr 1, 2026), with a median of $14.8346 per EA.
Are there cheaper alternatives to LIPITOR 40 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 40 MG TABLET, is $0.0370 per EA — about 99% below LIPITOR 40 MG TABLET.
Who manufactures LIPITOR 40 MG TABLET?
LIPITOR 40 MG TABLET (NDC 00071015723) is labeled by Pfizer Inc., and CMS classifies it as a brand product.